3 reports of this reaction
1.8% of all ARTHRITIS PAIN RELIEF reports
#14 most reported adverse reaction
NASOPHARYNGITIS is the #14 most commonly reported adverse reaction for ARTHRITIS PAIN RELIEF, manufactured by CVS Health. There are 3 FDA adverse event reports linking ARTHRITIS PAIN RELIEF to NASOPHARYNGITIS. This represents approximately 1.8% of all 170 adverse event reports for this drug.
Patients taking ARTHRITIS PAIN RELIEF who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NASOPHARYNGITIS is a less commonly reported adverse event for ARTHRITIS PAIN RELIEF, but still significant enough to appear in the safety profile.
In addition to nasopharyngitis, the following adverse reactions have been reported for ARTHRITIS PAIN RELIEF:
The following drugs have also been linked to nasopharyngitis in FDA adverse event reports:
NASOPHARYNGITIS has been reported as an adverse event in 3 FDA reports for ARTHRITIS PAIN RELIEF. This does not prove causation, but indicates an association observed in post-market surveillance data.
NASOPHARYNGITIS accounts for approximately 1.8% of all adverse event reports for ARTHRITIS PAIN RELIEF, making it a notable side effect.
If you experience nasopharyngitis while taking ARTHRITIS PAIN RELIEF, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.